The clinical potential of PDL-1 pathway and some related micro-RNAs as promising diagnostic markers for breast cancer
Abstract Background Immune checkpoint pathways play important roles in breast cancer (BC) pathogenesis and therapy. Methods Expression levels of programmed cell death protein 1 (PD-1), cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4), programmed death-ligand 1 (PD-L1), Forkhead box P3 (FOXP3), m...
Saved in:
| Main Authors: | Eman A. Al-Sharabass, Motawa E. EL-Houseini, Heba Effat, Sherif Abdelaziz Ibrahim, Mona S. Abdellateif |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-025-01137-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curcumin as a promising therapeutic agent for diabetic neuropathy: from molecular mechanisms to functional recovery
by: Shirin Barati, et al.
Published: (2025-08-01) -
The expression profile of inflammatory microRNAs in Leishmania major infected human macrophages; mining the effects of Leishmania RNA virus
by: Zahra Mirabedini, et al.
Published: (2025-04-01) -
Diagnostic and Prognostic Roles of miR-155 and miR-3173 in Breast and Ovarian Cancer: Implications for Early Detection and Personalized Treatment
by: Afaf Altrawy, et al.
Published: (2025-06-01) -
p53‐repressed miRNAs are involved with E2F in a feed‐forward loop promoting proliferation
by: Ran Brosh, et al.
Published: (2008-11-01) -
Elevated expression of microRNA-155, microRNA-383, and microRNA-9 in Iranian patients with polycystic ovary syndrome
by: Maryam Faraji, et al.
Published: (2025-06-01)